Sustained attention in cranial dystonia patients treated with botulinum toxin

10.1093/brain/121.7.1195

10.1002/mds.10205

Baker RS, 2003, J Neuroophthalmol, 23, 11, 10.1097/00041327-200303000-00003

Cakmur R, 2004, Adv Neurol, 94, 37

Curra A, 2000, Neurology, 54, 130, 10.1212/WNL.54.1.130

10.1002/ana.410370313

10.1002/mds.10595

10.1002/ana.20837

Milner B, 1963, Arch Neurol, 9, 90, 10.1001/archneur.1963.00460070100010

10.1016/0028-3932(68)90038-9

11.B Milner, JM Warren, and K Akert. The frontal granular cortex and behavior . New York: McGraw-Hill, 1964 ;313 -31 .

10.1016/0028-3932(74)90047-5

10.1016/0028-3932(90)90137-D

10.1093/brain/116.5.1159

Duane DD, 2004, Adv Neurol, 94, 179

10.1002/mds.10399

17.J Mueller, L Bartha, W Eisner, GK Wenning, T Benke, and W Poewe. The cognitive profile of primary dystonia: Preliminary findings of a prospective study . Rome: 8 International Congress of Parkinson Disease and Movement disorders, 2004;Poster286.

Riklan M, 1976, Adv Neurol, 14, 189

Gelb DJ, 1989, Neurology, 39, 80, 10.1212/WNL.39.1.80

Tsui JK, 1985, Can J Neurol Sci, 12, 314, 10.1017/S031716710003540X

10.1097/00002508-200503000-00010

Wellhoner HH, 1989, Botulinum neurotoxin and tetanus toxin, 231, 10.1016/B978-0-12-644445-2.50016-7

Simpson LL, 1981, Pharmacol Rev, 33, 155

10.1007/BF00505657

10.1093/brain/120.4.571

Esmaeli-Gutstein B, 1999, Ophthal Plast Reconstr Surg, 15, 23, 10.1097/00002341-199901000-00006

10.1097/01.wnf.0000152044.43822.42

10.1093/brain/97.1.793

29.O Spreen, and E Strauss. A compendium of neuropsychological tests: administration, norms, and commentary . New York: Oxford University Press, 1998 ;326 .

Teste Toulouse-Pieron, 1994, Bateria Cepa

Wechsler D, 1981, The Wechsler adult intelligence scale-revised

Lezak M, 1995, Neuropsychological Assessment

10.1002/1531-8257(200001)15:1<103::AID-MDS1016>3.0.CO;2-3

10.1001/archneur.60.5.782